BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427,917 | +1760.5% | 149,100 | +965.0% | 0.00% | – |
| Q3 2022 | $23,000 | -37.8% | 14,000 | -5.4% | 0.00% | – |
| Q2 2022 | $37,000 | -32.7% | 14,800 | -25.6% | 0.00% | – |
| Q1 2022 | $55,000 | -29.5% | 19,900 | +35.4% | 0.00% | -100.0% |
| Q4 2021 | $78,000 | -38.1% | 14,700 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $126,000 | -63.7% | 14,900 | -47.7% | 0.00% | -75.0% |
| Q2 2021 | $347,000 | -67.5% | 28,500 | -14.4% | 0.00% | -71.4% |
| Q4 2020 | $1,068,000 | +337.7% | 33,313 | +311.3% | 0.01% | +180.0% |
| Q3 2020 | $244,000 | – | 8,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
| Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
| Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
| Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
| Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
| DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
| RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
| Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
| MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
| K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |